Liu CQ, Hu B. Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease. World J Gastroenterol 2024; 30(25): 3179-3181 [PMID: 39006387 DOI: 10.3748/wjg.v30.i25.3179]
Corresponding Author of This Article
Bing Hu, MD, Editor-in-Chief, Professor, Department of Gastroenterology and Hepatology/Medical Engineering Integration Laboratory of Digestive Endoscopy, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, Sichuan Province, China. hubing@wchscu.edu.cn
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jul 7, 2024; 30(25): 3179-3181 Published online Jul 7, 2024. doi: 10.3748/wjg.v30.i25.3179
Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease
Cen-Qin Liu, Bing Hu
Cen-Qin Liu, Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
Bing Hu, Department of Gastroenterology and Hepatology/Medical Engineering Integration Laboratory of Digestive Endoscopy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
Author contributions: Liu CQ and Hu B co-authored and revised the manuscript; and both authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare no conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Bing Hu, MD, Editor-in-Chief, Professor, Department of Gastroenterology and Hepatology/Medical Engineering Integration Laboratory of Digestive Endoscopy, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, Sichuan Province, China. hubing@wchscu.edu.cn
Received: March 18, 2024 Revised: May 27, 2024 Accepted: June 17, 2024 Published online: July 7, 2024 Processing time: 105 Days and 0.2 Hours
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder, and dietary and lifestyle interventions remain the mainstays of NAFLD therapy. Zeng et al established a prediction system to evaluate adherence to lifestyle interventions in patients with NAFLD and choose optimal management. Here, we discuss the application scenarios of the scale and the areas warranting further attention, aiming to provide a possible reference for clinical recommendations.
Core Tip: Nonalcoholic fatty liver disease is the most common chronic liver disorder and the leading cause of cirrhosis and hepatocellular carcinoma. In this editorial, we aim to highlight the importance of a scale that can evaluate compliance with lifestyle interventions and guide the choice of targeted therapy. However, the universal applicability of the scale and the corresponding personalized treatment need to be carefully considered based on patients’ characteristics and doctors’ expertise.
